Comparative Proteomics Analysis Identifies Cdc42-Cdc42BPA Signaling as Prognostic Biomarker and Therapeutic Target for Colon Cancer Invasion | |
Hu, Hui-Fang[1]; Xu, Wen Wen[2]; Wang, Yang[1]; Zheng, Can-Can[1]; Zhang, Wei-Xia[1]; Li, Bin[1]; He, Qing-Yu[1] | |
2018 | |
卷号 | 17期号:1页码:265 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4462336 |
专题 | 暨南大学 |
作者单位 | 1.[1]Jinan Univ, Coll Life Sci & Technol, Inst Life & Hlth Engn, Key Lab Funct Prot Res,Guangdong Higher Educ Inst, Guangzhou 510632, Guangdong, Peoples R China 2.[2]Jinan Univ, Guangdong Prov Key Lab Bioengn Med, Natl Engn Res Ctr Genet Med, Inst Biomed, Guangzhou 510632, Guangdong, Peoples R China |
推荐引用方式 GB/T 7714 | Hu, Hui-Fang[1],Xu, Wen Wen[2],Wang, Yang[1],et al. Comparative Proteomics Analysis Identifies Cdc42-Cdc42BPA Signaling as Prognostic Biomarker and Therapeutic Target for Colon Cancer Invasion[J],2018,17(1):265. |
APA | Hu, Hui-Fang[1].,Xu, Wen Wen[2].,Wang, Yang[1].,Zheng, Can-Can[1].,Zhang, Wei-Xia[1].,...&He, Qing-Yu[1].(2018).Comparative Proteomics Analysis Identifies Cdc42-Cdc42BPA Signaling as Prognostic Biomarker and Therapeutic Target for Colon Cancer Invasion.,17(1),265. |
MLA | Hu, Hui-Fang[1],et al."Comparative Proteomics Analysis Identifies Cdc42-Cdc42BPA Signaling as Prognostic Biomarker and Therapeutic Target for Colon Cancer Invasion".17.1(2018):265. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论